#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13782	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2193	625.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1529	1529	C	837	C,A	777,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13782	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2193	625.9	0	HET	.	.	.	C226T	.	226	226	C	571	571	C	730	C,T	511,167	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3604	693.0	0	.	n	.	0	T695C	SNP	695	695	T	1080	1080	C	783	C	731	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3604	693.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2023	2023	G	816	G,A	613,152	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3604	693.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2356	2356	C	831	C,T	759,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3604	693.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2430	2430	A	786	A	728	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3604	693.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2982	2982	C	801	C	743	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3604	693.0	0	HET	.	.	.	C539T	.	539	539	C	924	924	C	775	C,T	557,171	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	14	blaTEM	861	239	100.0	blaTEM.l15.c4.ctg.1	239	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1746	folP	855	855	100.0	folP.l15.c4.ctg.1	1576	110.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1067	1069	AGC	183;185;184	A;G;C	174;177;175	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4464	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3495	127.5	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	157;157;159	T;T;C	145;144;147	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4464	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3495	127.5	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	156;156;156	G;G;C	147;147;146	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4464	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3495	127.5	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	156;156;156	G;G;C	147;147;146	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1444	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1345	106.9	1	SNP	p	G45D	0	.	.	133	135	GGC	515	517	GGC	194;193;190	G;G,A;C	175;171,1;170	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	712	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1066	66.6	0	.	n	.	0	A197.	DEL	197	197	A	640	640	A	185	A	170	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4534	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	153.9	1	SNP	p	D86N	0	.	.	256	258	GAC	575	577	GAC	194;194;192	G;A;C	177;172;179	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4534	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	153.9	1	SNP	p	R87I	0	.	.	259	261	CGT	578	580	CGT	190;185;185	C;G;T	180;175;170	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4534	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	153.9	1	SNP	p	S87R	1	.	.	259	261	CGT	578	580	CGT	190;185;185	C;G;T	180;175;170	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4534	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	153.9	1	SNP	p	R87W	0	.	.	259	261	CGT	578	580	CGT	190;185;185	C;G;T	180;175;170	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4534	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2936	153.9	1	SNP	p	S88P	0	.	.	262	264	TCC	581	583	TCC	188;188;189	T;C;C	174;175;179	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3722	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2606	142.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1570	1572	GGC	183;180;181	G;G;C	169;168;167	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1161	1163	GCA	214;213;214	G;C;A	193;193;195	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1164	1166	ATC	214;214;217	A;T;C	196;195;195	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1176	1178	GTG	220;214;217	G;T;G	195;190;193	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1176	1178	GTG	220;214;217	G;T;G	195;190;193	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1680	1682	ACC	181;182;182	A;C;C	161;166;164	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1734	1736	GCG	172;170;166	G;C;G	149;137;145	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1734	1736	GCG	172;170;166	G;C;G	149;137;145	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1857	1859	AGC	142;140;140	A;G,A;C	135;132,1;132	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1866	1868	GGC	137;137;137	G;G;C	127;126;126	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3596	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2282	157.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1884	1886	CCG	125;130;136	C,G;C;G	91,2;93;101	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4918	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3064	160.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	152;154;155	C;C;G,C	132;140;135,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1762	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1795	97.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	131	C	120	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	349	38.2	0	.	p	.	0	M18T	NONSYN	52	54	ATG	279	281	ACG	73;71;66	A;C;G	67;65;60	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	349	38.2	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	321	323	CAA	28;27;26	C;A;A	26;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	349	38.2	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	327	329	TAC	22;19;17	T;A;C	21;18;17	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	504	506	GAA	241;235;232	G;A;A	225;221;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	792	794	GAT	227;229;230	G;A;T	210;213;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	915	917	TCA	212;212;212	T;C;A	195;194;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1044	1046	GTC	190;187;187	G;T;C	178;176;177	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1056	1058	TCT	188;188;188	T;C;T	182;182;181	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1206	1208	GTG	240;241;243	G;T,C;G	219;218,1;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1374	1376	GCA	219;219;221	G;C;A	204;200;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	1	SNP	p	G120K	1	.	.	358	360	AAG	750	752	AAG	218;218;216	A;A;G	208;208;206	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	1	SNP	p	D121N	0	.	.	361	363	GAC	753	755	GAC	216;218;218	G;A;C	205;206;207	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2658	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1582	167.4	1	SNP	p	A121D	1	.	.	361	363	GAC	753	755	GAC	216;218;218	G;A;C	205;206;207	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10688	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4879	218.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1124	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1207	92.8	1	SNP	p	V57M	1	.	.	169	171	ATG	639	641	ATG	210;212;213	A;T;G	197;196;198	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
